Couverture de S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story

S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story

S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story

Écouter gratuitement

Voir les détails

À propos de ce contenu audio

 Bradley Burnam, the founder and CEO of Turn Therapeutics, discusses his journey in the pharmaceutical landscape: from his battle with an aggressive antimicrobial resistant infection to the beginnings of Turn, and to the current state of Hexagen technology and its potential in eczema, onychomycosis, and more.
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Aucun commentaire pour le moment